Trastuzumab Completed Phase 1 Trials for Breastcancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03014076Immunotherapy Vaccine and Herceptin in Breast Cancer